Detalles de la búsqueda
1.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
Lancet Oncol
; 18(7): 895-903, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551359
2.
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
Cancer
; 123(24): 4800-4807, 2017 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29125624
3.
Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy.
J Natl Compr Canc Netw
; 18(9): 1287-1290, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886906
4.
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536938
5.
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
J Clin Oncol
; 41(29): 4678-4687, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37327461
6.
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
J Immunother Cancer
; 11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37730274
7.
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 117(1): 118-122, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37023987
Resultados
1 -
7
de 7
1
Próxima >
>>